GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...

Pharmaceutical REMS Market SizeThe global pharmaceutical REMS market — a critical safety framework for high‑risk drugs — is ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

Daemon is excited to announce it is a recipient of a 2025 Geography and Global AWS Partner Award, recognising leaders around the globe that are playing key roles in helping their customers drive ...

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → ...

SIOUX FALLS, SD / ACCESS Newswire / December 2, 2025 / Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of ...

This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the ...

Axoltis Pharma, a biotech company dedicated to developing novel therapeutic solutions for neurodegenerative diseases, today announces the closing of a Series A funding round worth €18 million ($20.9M) ...

IonQ serves as strategic quantum technology partner across CCRM’s leading global regenerative medicine network COLLEGE PARK, MD – December 1, 2025 - IonQ (NYSE: IONQ), the world’s leading quantum ...

Funds will enable launch of AI-powered R&D center and bring BiPER Tx’s selective BiP (GRP78) inhibitor clinical candidate BPR001-615 a step closer to entering phase 1/2a clinical trial in ...